These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 12243977)
1. Treatment of lymphoid malignancies with non-myeloablative stem cell transplantation. Seftel MD; Lavoie J; Barnett MJ; Conneally E Hematology; 2002 Jun; 7(3):151-5. PubMed ID: 12243977 [TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
3. Update on non-myeloablative stem cell transplantation for hematologic malignancies. Giralt S Int J Hematol; 2002 Aug; 76 Suppl 1():368-75. PubMed ID: 12430884 [TBL] [Abstract][Full Text] [Related]
4. A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations. Atilla E; Ataca Atilla P; Demirer T Balkan Med J; 2017 Jan; 34(1):1-9. PubMed ID: 28251017 [TBL] [Abstract][Full Text] [Related]
5. Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy. Levine JE; Uberti JP; Ayash L; Reynolds C; Ferrara JL; Silver SM; Braun T; Yanik G; Hutchinson R; Ratanatharathorn V Biol Blood Marrow Transplant; 2003 Mar; 9(3):189-97. PubMed ID: 12652470 [TBL] [Abstract][Full Text] [Related]
12. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [TBL] [Abstract][Full Text] [Related]
13. [Ten years of changes in conditioning regimen for allogenic hematopoietic stem cell transplantation in adults]. Peffault de Latour R; Cabrespine-Faugeras A; Bay JO Bull Cancer; 2008 Jan; 95(1):87-97. PubMed ID: 18230574 [TBL] [Abstract][Full Text] [Related]
14. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. Resnick IB; Shapira MY; Slavin S Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565 [TBL] [Abstract][Full Text] [Related]
15. Reduced-intensity hematopoietic stem cell transplants for malignancies: harnessing the graft-versus-tumor effect. Gill S; Porter DL Annu Rev Med; 2013; 64():101-17. PubMed ID: 23121181 [TBL] [Abstract][Full Text] [Related]